Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ark Genomic Revolution ETF (ARKG)

Ark Genomic Revolution ETF (ARKG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 8,669,572,000
  • Shares Outstanding, K 102,055
  • 60-Month Beta 1.56
Trade ARKG with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.79 (0.93%)
  • Most Recent Dividend 0.790 on 12/29/20
  • Management Fee 0.75%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 35.70%
  • Historical Volatility 27.09%
  • IV Percentile 14%
  • IV Rank 10.00%
  • IV High 68.15% on 03/05/21
  • IV Low 32.09% on 06/25/21
  • Put/Call Vol Ratio 0.70
  • Today's Volume 890
  • Volume Avg (30-Day) 9,864
  • Put/Call OI Ratio 1.01
  • Today's Open Interest 200,820
  • Open Int (30-Day) 270,033

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.74 +5.35%
on 07/15/21
93.63 -9.15%
on 07/02/21
-7.44 (-8.04%)
since 06/30/21
3-Month
72.07 +18.02%
on 05/13/21
94.14 -9.65%
on 06/30/21
-3.81 (-4.29%)
since 04/30/21
52-Week
52.80 +61.10%
on 09/04/20
115.15 -26.13%
on 02/10/21
+30.39 (+55.59%)
since 07/30/20

Most Recent Stories

More News
Tech Bubble 2.0 + Inflation Tsunami: How to Play Them Now

Morgan Stanley warns investors 15% correction coming as market overvalued like dot-com days.

AMD : 106.90 (+3.84%)
NVDA : 194.26 (-1.20%)
TSLA : 696.00 (+2.75%)
NVTA : 28.24 (+0.57%)
ARKG : 85.08 (+0.07%)
A Comprehensive Guide to Genomic ETFs

Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

BEAM : 92.70 (+2.58%)
EDIT : 42.31 (+0.98%)
PBE : 75.38 (+0.12%)
NTLA : 142.23 (+3.80%)
CRSP : 120.87 (+1.57%)
ARKG : 85.08 (+0.07%)
GNOM : 23.01 (+0.70%)
IDNA : 50.16 (+0.26%)
Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

REGN : 574.73 (-1.44%)
BEAM : 92.70 (+2.58%)
EDIT : 42.31 (+0.98%)
NTLA : 142.23 (+3.80%)
CRSP : 120.87 (+1.57%)
ARKG : 85.08 (+0.07%)
GNOM : 23.01 (+0.70%)
IDNA : 50.16 (+0.26%)
Top-Performing Biotech ETFs of Last Week

Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.

BIIB : 329.46 (+0.09%)
FBT : 169.02 (+0.30%)
SBIO : 44.18 (-1.38%)
BTEC : 56.11 (-0.30%)
ARKG : 85.08 (+0.07%)
GNOM : 23.01 (+0.70%)
ORPH : 4.77 (-1.04%)
CLOV : 8.21 (-0.12%)
Ride the Renewed Meme Stock Wave With This New ETF

Meme stocks are those that grabbed immense investor interest due to hype on social media and online forums like Reddit, WallStreetBets and Robinhood, rather than the company fundamentals, resulting in...

UNH : 412.48 (+0.10%)
CSCO : 55.38 (+0.56%)
GME : 160.48 (-2.66%)
AMC : 37.81 (-0.84%)
ARKQ : 81.40 (-0.06%)
ARKW : 148.22 (-0.65%)
ARKK : 120.95 (-0.53%)
BB : 10.16 (-1.84%)
ARKG : 85.08 (+0.07%)
KDP : 35.30 (+1.00%)
ARKF : 50.89 (-2.02%)
FOMO : 25.43 (-0.13%)
Likely Capital Gain Tax Hike a Buying Point for These ETFs?

President Joe Biden wants to raise capital gains tax to 39.6% from the current rate of 20% for those earning $1 million or more. Since the group is just 0.3% of total population, don't expect a severe...

PTF : 150.64 (-0.42%)
XRT : 95.56 (-0.54%)
PSI : 127.29 (+0.77%)
PBW : 83.74 (+0.37%)
ARKW : 148.22 (-0.65%)
IBUY : 121.20 (-2.05%)
LIT : 83.42 (+0.88%)
IPO : 63.06 (+0.21%)
ARKG : 85.08 (+0.07%)
NERD : 28.41 (-0.85%)
Thematic Investing on the Rise: ARK ETFs Leading the Pack

Thematic ETFs saw net inflows of $42.6 billion in the first two months of this year, more than three times the $13.3 billion garnered in the same period last year.

ARKQ : 81.40 (-0.06%)
ARKW : 148.22 (-0.65%)
ARKK : 120.95 (-0.53%)
ARKG : 85.08 (+0.07%)
ARKF : 50.89 (-2.02%)
Bear of the Day: CRISPR Therapeutics (CRSP)

Bear of the Day: CRISPR Therapeutics (CRSP)

NTLA : 142.23 (+3.80%)
EDIT : 42.31 (+0.98%)
CRSP : 120.87 (+1.57%)
ARKK : 120.95 (-0.53%)
ARKG : 85.08 (+0.07%)
Ark Invest ETFs Power Active Investing Growth

Active ETFs pulled in a record of more than $55 billion capital last year and $17.5 billion so far this year, bringing their AUM to $200 billion.

ARKQ : 81.40 (-0.06%)
ARKW : 148.22 (-0.65%)
ARKK : 120.95 (-0.53%)
ARKG : 85.08 (+0.07%)
ARKF : 50.89 (-2.02%)
6 Hot ETFs That Could be Investors' Darling in February

A few ETFs have garnered solid investors' interest to start a New Year and will continue to be their darlings in the month of love.

AMZN : 3,353.61 (-6.84%)
GME : 160.48 (-2.66%)
XLF : 36.62 (-0.52%)
TSLA : 696.00 (+2.75%)
GOOGL : 2,693.24 (-0.82%)
VTI : 227.08 (-0.42%)
IEMG : 63.38 (-0.61%)
ARKK : 120.95 (-0.53%)
EFV : 51.65 (-0.75%)
ARKG : 85.08 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials,...

See More

Key Turning Points

3rd Resistance Point 87.03
2nd Resistance Point 86.49
1st Resistance Point 85.76
Last Price 85.09
1st Support Level 84.49
2nd Support Level 83.95
3rd Support Level 83.22

See More

52-Week High 115.15
Fibonacci 61.8% 91.33
Last Price 85.09
Fibonacci 50% 83.97
Fibonacci 38.2% 76.62
52-Week Low 52.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar